Zynex Ratio court
Quel est le Ratio court de Zynex?
Le Ratio court de Zynex, Inc. est 25.86
Quelle est la définition de Ratio court?
Le ratio court des actions vendues est le nombre d'actions vendues à découvert divisé par le volume quotidien moyen.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Ratio court des entreprises dans Health Care secteur sur XETRA par rapport à Zynex
Que fait Zynex?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Entreprises avec ratio court similaire à Zynex
- Kadmon Inc a Ratio court de 25.51
- Kadmon a Ratio court de 25.51
- AnaptysBio Inc a Ratio court de 25.65
- Microvision a Ratio court de 25.65
- Taseko Mines a Ratio court de 25.71
- Canadian Imperial Bank Of Commerce a Ratio court de 25.79
- Zynex a Ratio court de 25.86
- Resolute Forest Products a Ratio court de 26.15
- Slate Office REIT a Ratio court de 26.20
- Evelo Biosciences Inc a Ratio court de 26.22
- Propel a Ratio court de 26.23
- Atossa Therapeutics Inc a Ratio court de 26.50
- Knight Therapeutics a Ratio court de 26.62